C.R.S. Section 12-280-117
Continuing education

  • exceptions
  • inactive status

(1)

Except as permitted in subsections (2) and (3) of this section, the board shall not renew, reinstate, or reactivate the license of any pharmacist until the pharmacist presents evidence that he or she has completed twenty-four hours of approved continuing pharmaceutical education within the preceding two years. Subject to subsection (9) of this section, the evidence may be provided by checking a sign-off box on the license renewal application.

(2)

Intentionally left blank —Ed.

(a)

The board may renew the license of a pharmacist who presents acceptable evidence that the pharmacist was unable to comply with subsection (1) of this section.

(b)

The board may grant a six-month compliance extension to pharmacists who are unable to comply with subsection (1) of this section.

(3)

The board may renew the license for the first renewal period following the issuance of the original license without requiring a pharmacist to complete any continuing pharmaceutical education if the pharmacist obtains a license within one year after the completion of the pharmacist’s pharmaceutical education.

(4)

To qualify for continuing education credit, a program of continuing pharmaceutical education must be currently approved by the Accreditation Council for Pharmacy Education or an equivalent accrediting body as determined by the board.

(5)

Each program of continuing pharmaceutical education must consist of at least one continuing education unit, which is one hour of participation in an organized continuing educational experience, including postgraduate studies, institutes, seminars, lectures, conferences, workshops, correspondence courses, audio programs, programmed learning courses, audiovisual programs, internet programs, and any other form of presentation that is accredited.

(6)

Any aspect of the practice of pharmacy may be the subject of a program of continuing pharmaceutical education, including pharmaceutics, compounding, pharmacology, pharmaceutical chemistry, biochemistry, physiology, microbiology, pharmacy administration, and professional practice management.

(7)

A program of continuing pharmaceutical education may include the following:

(a)

A definite stated objective;

(b)

Presentation in an organized manner; and

(c)

A method of program evaluation that is suitable to the type of program being presented.

(8)

A program of continuing pharmaceutical education must meet the requirements as established by the accrediting body.

(9)

The board may annually audit up to five percent of the pharmacists licensed and residing in Colorado to determine compliance with this section.

(10)

If a licensed pharmacist fails to obtain the twenty-four hours of approved continuing pharmaceutical education, the pharmacist’s license becomes inactive. An inactive licensee is not required to comply with any continuing pharmaceutical education requirement so long as the licensee remains inactive, but the licensee must continue to pay applicable fees, including renewal fees. The board shall note “inactive status” on the face of any license it issues to a licensee while the licensee remains inactive. Should an inactive pharmacist wish to resume the practice of pharmacy after being placed on an inactive list, the pharmacist shall file an application to activate his or her license, pay the license renewal fee, and, subject to subsections (2) and (3) of this section, meet the twenty-four-hour continuing education requirement. If a licensed pharmacist engages in the practice of pharmacy while on inactive status, that conduct may be grounds for license revocation under this article 280.

Source: Section 12-280-117 — Continuing education - exceptions - inactive status, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-12.­pdf (accessed Oct. 20, 2023).

12‑280‑101
Public interest - rules
12‑280‑102
Applicability of common provisions
12‑280‑103
Definitions - rules
12‑280‑104
State board of pharmacy - creation - subject to review - repeal of parts
12‑280‑105
Membership of board - removal - compensation - meetings
12‑280‑106
Veterinary pharmaceutical advisory committee - creation - appointments - rules - repeal
12‑280‑107
Rules
12‑280‑108
Powers and duties - rules
12‑280‑109
Drugs, devices, and other materials
12‑280‑110
Publications
12‑280‑111
Malpractice claims information - not public - exception
12‑280‑112
Fees
12‑280‑113
Approval of schools
12‑280‑114
Licensure, certification, or registration - applicability - applications - licensure and certification requirements - rules
12‑280‑115
Exemptions from licensure - hospital residency programs - home renal dialysis - research companies
12‑280‑115.5
Certification of pharmacy technicians - requirements - provisional certification - criminal history record check - rules
12‑280‑116
Expiration and renewal of licenses, certifications, or registrations
12‑280‑117
Continuing education - exceptions - inactive status
12‑280‑117.5
Continuing education for pharmacy technicians - exceptions - inactive status
12‑280‑118
Prescription drug outlet under charge of pharmacist - rules
12‑280‑119
Registration of facilities - rules
12‑280‑120
Compounding - dispensing - sale of drugs and devices - rules - definition
12‑280‑121
Compounding drugs for office use by a veterinarian - rules - definitions
12‑280‑122
Limited authority to delegate activities constituting practice of pharmacy to pharmacy interns or pharmacy technicians
12‑280‑123
Prescription required - exception - dispensing opiate antagonists - selling nonprescription syringes and needles
12‑280‑124
Labeling - rules
12‑280‑125
Substitution of prescribed drugs and biological products authorized - when - conditions
12‑280‑125.3
Pharmacists’ authority - minor prescription adaptions
12‑280‑125.5
Pharmacists’ authority to dispense chronic maintenance drugs - rules - liability
12‑280‑125.7
Pharmacists’ authority to prescribe and dispense HIV prevention drugs - definitions - rules
12‑280‑126
Unprofessional conduct - grounds for discipline
12‑280‑127
Disciplinary actions
12‑280‑128
Judicial review
12‑280‑129
Unlawful acts - civil fines
12‑280‑130
Unauthorized practice - penalties
12‑280‑131
New drugs - when sales permissible
12‑280‑132
Advertising of prescription drug prices
12‑280‑133
Nonresident prescription drug outlet - registration
12‑280‑133.5
Nonresident 503B outsourcing facility - registration - requirements - denial, revocation, or suspension - rules
12‑280‑133.7
Third-party logistics providers - registration - denial, revocation, or suspension - rules
12‑280‑134
Records
12‑280‑135
Unused medication - licensed facilities - correctional facilities - reuse - definitions - rules
12‑280‑136
Confidential agreement to limit practice
12‑280‑137
Investigations of suspicious drugs
12‑280‑138
Patient counseling - pharmacists required to perform - patient may decline - rules
12‑280‑139
Insulin affordability program - record keeping - reimbursement - definitions
12‑280‑140
Emergency prescription insulin supply - eligibility - record keeping
12‑280‑141
Prescription drugs - automated pharmacy dispensing system - rules - definition
12‑280‑142
Epinephrine auto-injector affordability program - record keeping - reimbursement - definitions
12‑280‑201
Legislative declaration
12‑280‑202
Definitions
12‑280‑203
Pharmacy peer health assistance fund - rules
12‑280‑204
Eligibility - participants
12‑280‑205
Liability
12‑280‑206
Immunity
12‑280‑301
Definitions
12‑280‑303
Wholesaler registration requirements - rules
12‑280‑304
Record check
12‑280‑305
Restrictions on transactions
12‑280‑306
Records - pedigree - compliance with DQSA
12‑280‑307
Penalty
12‑280‑308
Manufacturer, agent, representative, or employee - drug cost information - required - definitions
12‑280‑401
Legislative declaration
12‑280‑402
Definitions
12‑280‑403
Prescription drug use monitoring program - registration required - applications - rules - appropriation - repeal
12‑280‑404
Program operation - access - rules - definitions
12‑280‑405
Prescription drug monitoring fund - creation - fee
12‑280‑406
Violations - penalties
12‑280‑407
Prescription drug outlets - prescribers - responsibilities - liability
12‑280‑408
Exemption - waiver
12‑280‑409
Examination and analysis of prescription drug monitoring program - recommendations to executive director
12‑280‑501
Written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections
12‑280‑502
Therapeutic interchange and therapeutically equivalent selections for nursing care facility or long-term acute care hospital patients - rules
12‑280‑601
Definitions
12‑280‑602
Collaborative pharmacy practice agreements - pharmacist requirements
12‑280‑603
Rules
Green check means up to date. Up to date

Current through Fall 2024

§ 12-280-117’s source at colorado​.gov